Medpace Holdings, Inc.【MEDP】Cash flow
Market cap
$16.7B
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 10 | 4 | 6 | 21 | 14 | 14 | 21 | 21 | 26 |
| Cash from operations | 92 | 97 | 157 | 202 | 259 | 263 | 388 | 433 | 609 |
| Capital expenditures | -14 | -12 | -16 | -18 | -31 | -28 | -37 | -37 | -37 |
| Cash from investing | -13 | -12 | -17 | -19 | -31 | -31 | -39 | -35 | -28 |
| Repurchases of common stock | - | 156 | - | - | 98 | 62 | 848 | 144 | 170 |
| Cash from financing | -58 | -98 | -142 | -74 | -82 | -44 | -776 | -183 | -154 |
| Free cash flow | |||||||||
| FCF margin (%) |